VMP 39116311000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Indacaterol 125micrograms/dose / Mometasone 127.5micrograms/dose inhalation powder capsules with device
BNF code 0302000X0AAABAB
Virtual Therapeutic Moiety Indacaterol + Mometasone
Abbreviated name Indacaterol 125microg/Mometasone 127.5microg/dose pdr caps
Basis of preferred name Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Indacaterol acetate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 702801003
Strength value numerator 125.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Virtual Product Ingredient
Ingredient Mometasone furoate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 127.500
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Ontology Drug Form & Route
Form & Route powderinhalation.inhalation
Dose Form
Formulation Inhalation powder
Drug Route
Route Inhalation
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device (Sandoz Ltd)
Virtual Medicinal Product Packs
Indacaterol 125micrograms/dose / Mometasone 127.5micrograms/dose inhalation powder capsules with device 30 capsule

dm+d data retrieved from TRUD: release NHSBSA_8.1.0_20220808000001, imported on 8th August 2022 at 04:49:10.